Synthesis and characterization of polar functional group substituted mono- and bis-(o-carboranyl)-1,3,5-triazine derivatives

Tetrahedron Letters

Volumn 49, Issue 1, 2008, Pages 159-164

  Lee, Chai Ho ^a   Jin, Guo Fan ^a   Yoon, Ji Ho ^a   Jung, Young Ju ^a   Lee, Jong Dae ^b   Cho, Sungdong ^b   Nakamura, Hiroyuki ^c   Kang, Sang Ook ^d  

^a Wonkwang University   (South Korea)

^b Chosun University   (South Korea)

^c GAKUSHUIN UNIVERSITY   (Japan)

^d Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2 CARBORAN 1 YL) 2,4 BIS[BIS(2 HYDROXYETHYL)AMINO] 1,3,5 TRIAZINE; 6 (2 CARBORAN 1 YL) 2,4 BIS[BIS(2 METHOXYETHYL)AMINO] 1,3,5 TRIAZINE; AMINE; CARBORANE DERIVATIVE; FUNCTIONAL GROUP; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DEMETHYLATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; X RAY CRYSTALLOGRAPHY;

EID: 36549082809     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.10.145     Document Type: Article

References (24)

1. Chen J., Cai D., Jin W., Wu F., and Chen X. J. Appl. Polym. Sci. 102 (2006) 1291
2. Saçzewski F., and Bulakowska A. Eur. J. Med. Chem. 41 (2006) 611
3. Januszko A., Kaszynski P., and Drzewinski W. J. Mater. Chem. 16 (2006) 452
4. Brzozowski Z., and Saçzewski F. Eur. J. Med. Chem. 37 (2002) 709
5. Azev Y., Slepukhina I., and Gabel D. Appl. Radiat. Isot. 61 (2004) 1107
6. Coley H.M., Brooks N., Phillips D.H., Hewer A., Jenkins T.C., Jarman M., and Judson I.R. Biochem. Pharm. 49 (1995) 1203
7. Gulevskaya A.V., Maes B.U.W., and Meyers C. Synlett (2007) 71
8. Maheswari P.U., Modec B., Pevec A., Kozlevčar B., Massera C., Gamez P., and Reedijk J. Inorg. Chem. 45 (2006) 6637
9. Shastin A.V., Godovikova T.I., and Korsunskii B.L. Chem. Heterocycl. Compd. 39 (2003) 624
10. Mooibroek T.J., and Gamez P. Inorg. Chim. Acta 360 (2007) 381
11. Meier H., Karpuk E., and Holst H.C. Eur. J. Org. Chem. (2006) 2609
12. Valliant J.F., Guether K.J., King A.S., Morel P., Schaffer P., Sogbein O.O., and Stephenson K.A. Coord. Chem. Rev. 232 (2002) 173
13. Lee C.-H., Lim H.-G., Lee J.-D., Lee Y.-J., Ko J., Nakamura H., and Kang S.O. Appl. Organomet. Chem. 17 (2003) 539
14. Hawthorne M.F. Angew. Chem., Int. Ed. Engl. 32 (1993) 950
15. Soloway A.H., Tjarks W., Barnum A., Rong F.-G., Barth R.F., Codogni I.M., and Wilson J.G. Chem. Rev. 98 (1998) 1515
16. Reynolds R.C., Campbell S.R., Fairchild R.G., Kisliuk R.L., Micca P.L., Queener S.F., Riordan J.M., Sedwick W.D., Waud W.R., Leung A.K.W., Dixon R.W., Suling W.J., and Borhani D.W. J. Med. Chem. 50 (2007) 3283
17. Ogawa T., Ohta K., Yoshimi T., Yamazaki H., Suzuki T., Ohta S., and Endo Y. Bioorg. Med. Chem. Lett. 16 (2006) 3943
18. Goto T., Ohta K., Suzuki T., Ohta S., and Endo Y. Bioorg. Med. Chem. 13 (2005) 6414
19. Unpublished results.
20. 3) δ 28.1, 50.0-50.2, 81.9, 165.4, 168.3-168.5, 169.3.
21. 3) δ 28.1, 51.2, 56.2, 72.4, 83.3, 164.4, 167.2, 167.9.
22. 6) δ 51.2-51.6, 57.6, 59.0, 73.5, 164.0, 167.3. Compounds 15 and 16: A trifluoroacetic acid (8 mL) solution containing compound 11 (1.41 g, 2 mmol) or 12 (1.22 g, 2 mmol) was stirred for 24 h at room temperature and then dried in vacuo. However, we did not obtain the de-alkylated compounds.
23. Asayama S., Mizushima K., Nagaoka S., and Kawakami H. Bioconjugate Chem. 15 (2004) 1360
24. Tietze L.F., Bothe U., Griesbach U., Nakaichi M., Hasegawa T., Nakamura H., and Yamamoto Y. ChemBioChem 2 (2001) 326-334